Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HemoCue AB

Division of Danaher Corp.
www.hemocue.com

Latest From BioVex Ltd.

British Biotechs Urge U.K. Government To Import French Private Investment Vehicle

British biotech companies want the U.K. government to adopt a French method of funneling funds into the cash-strapped sector from private individuals in return for favorable rates of investment tax, on grounds that a version of France’s long-running Fonds Commun de Placement dans l'Innovation is needed for small-to-medium-sized biopharma companies in Britain to tap successfully into long-term seed capital.

BioPharmaceutical United Kingdom

EU's CHMP Clears Europe's First Gene Therapy, UniQure's Glybera

After three previous negative votes, the Netherlands biotech uniQure gains the first positive opinion from the Committee for Medicinal Products for Human Use for a gene therapy in Europe. Glybera is used to treat the ultra-rare condition lipoprotein lipase deficiency.

BioPharmaceutical Europe

immatics biotechnologies GMBH

immatics biotechnologies GMBH aims to identify tumor-associated peptides by directly measuring their presence in cancer tissue and then creating cancer vaccines from combinations of the most prevalent peptides associated with a particular tumor. The Tuebingen-based firm's proprietary platform combines genomics, mass spectrometry and cell-based assay systems to offer better speed and precision than existing technologies.
BioPharmaceutical Europe

Recent Dealmaking (11/2003)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Glucose Testing
    • Hematology, Coagulation
    • Urine-based Testing
  • Medical Devices
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Alias(es)
  • HemoCue Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Danaher Corp.
  • Senior Management
  • Neils Christiansen, Pres.
  • Contact Info
  • HemoCue AB
    Phone: (46) 734 140003
    Box 1204
    Ängelholm, 262 23
    Sweden
Advertisement
Advertisement
UsernamePublicRestriction

Register